CA1223831A
(en)
|
1982-06-23 |
1987-07-07 |
Dean Engelhardt |
Modified nucleotides, methods of preparing and utilizing and compositions containing the same
|
US4948882A
(en)
*
|
1983-02-22 |
1990-08-14 |
Syngene, Inc. |
Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis
|
US5821058A
(en)
|
1984-01-16 |
1998-10-13 |
California Institute Of Technology |
Automated DNA sequencing technique
|
USRE43096E1
(en)
|
1984-01-16 |
2012-01-10 |
California Institute Of Technology |
Tagged extendable primers and extension products
|
JPH0692392B2
(ja)
*
|
1986-04-04 |
1994-11-16 |
信彦 勝沼 |
新規プソイドウリジン誘導体
|
US5384241A
(en)
*
|
1987-09-11 |
1995-01-24 |
Enzo Diagnostics, Inc. |
Specific binding assay compound with inhibitive self-quenching characteristics
|
US4965349A
(en)
*
|
1987-12-24 |
1990-10-23 |
Applied Biosystems, Inc. |
Method of synthesizing oligonucleotides labeled with ammonia-labile groups on solid phase supports
|
DE68917479D1
(de)
*
|
1988-02-24 |
1994-09-15 |
Inst Rech Chim Biolog |
Derivate von deoxy-2'-uridin substituiert in der 5, 3' oder 5' stellung durch acylierte alpha-amino-gruppen, verfahren zur herstellung und arzneimittel daraus.
|
US5324831A
(en)
*
|
1988-04-06 |
1994-06-28 |
The United States Of America As Represented By The Secretary Of Health And Human Services |
Phosphoramidite reagent for chemical synthesis of modified DNA
|
DE3835772A1
(de)
*
|
1988-10-20 |
1990-04-26 |
Deutsches Krebsforsch |
Tumorhemmende saccharid-konjugate
|
IT1228293B
(it)
*
|
1989-02-06 |
1991-06-07 |
Angeli Inst Spa |
Benzoderivati di composti eterociclici contenenti azoto.
|
US5256775A
(en)
*
|
1989-06-05 |
1993-10-26 |
Gilead Sciences, Inc. |
Exonuclease-resistant oligonucleotides
|
KR920701230A
(ko)
*
|
1989-06-05 |
1992-08-11 |
원본미기재 |
엑소뉴클레아제-내성 올리고뉴클레오티드 및 그 제조방법
|
US5424186A
(en)
|
1989-06-07 |
1995-06-13 |
Affymax Technologies N.V. |
Very large scale immobilized polymer synthesis
|
US6416952B1
(en)
|
1989-06-07 |
2002-07-09 |
Affymetrix, Inc. |
Photolithographic and other means for manufacturing arrays
|
US6346413B1
(en)
|
1989-06-07 |
2002-02-12 |
Affymetrix, Inc. |
Polymer arrays
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
US6040138A
(en)
|
1995-09-15 |
2000-03-21 |
Affymetrix, Inc. |
Expression monitoring by hybridization to high density oligonucleotide arrays
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
US6551784B2
(en)
|
1989-06-07 |
2003-04-22 |
Affymetrix Inc |
Method of comparing nucleic acid sequences
|
US6955915B2
(en)
|
1989-06-07 |
2005-10-18 |
Affymetrix, Inc. |
Apparatus comprising polymers
|
US6309822B1
(en)
|
1989-06-07 |
2001-10-30 |
Affymetrix, Inc. |
Method for comparing copy number of nucleic acid sequences
|
US6406844B1
(en)
|
1989-06-07 |
2002-06-18 |
Affymetrix, Inc. |
Very large scale immobilized polymer synthesis
|
US6919211B1
(en)
|
1989-06-07 |
2005-07-19 |
Affymetrix, Inc. |
Polypeptide arrays
|
US5800992A
(en)
|
1989-06-07 |
1998-09-01 |
Fodor; Stephen P.A. |
Method of detecting nucleic acids
|
US5141813A
(en)
*
|
1989-08-28 |
1992-08-25 |
Clontech Laboratories, Inc. |
Multifunctional controlled pore glass reagent for solid phase oligonucleotide synthesis
|
EP0942000B1
(de)
*
|
1989-10-24 |
2004-06-23 |
Isis Pharmaceuticals, Inc. |
2'-Modifizierte Oligonukleotide
|
US6005087A
(en)
*
|
1995-06-06 |
1999-12-21 |
Isis Pharmaceuticals, Inc. |
2'-modified oligonucleotides
|
US6506558B1
(en)
|
1990-03-07 |
2003-01-14 |
Affymetrix Inc. |
Very large scale immobilized polymer synthesis
|
BR9106702A
(pt)
*
|
1990-07-27 |
1993-06-08 |
Isis Pharmaceuticals Inc |
Analogo de oligonucleotideos e processos para modular a producao de uma proteina por um organismo e para tratar um organismo
|
EP0549709B1
(de)
*
|
1990-09-20 |
1997-01-29 |
Amoco Corporation |
Sonde zusammensetzungen für chromosom identifizierung und verfahren
|
DE69132843T2
(de)
|
1990-12-06 |
2002-09-12 |
Affymetrix Inc N D Ges D Staat |
Identifizierung von Nukleinsäuren in Proben
|
YU187991A
(sh)
*
|
1990-12-11 |
1994-09-09 |
Hoechst Aktiengesellschaft |
3-(2)-amino-ali tiol-modifikovani, s fluorescentnom bojom vezani nukleozidi, nukleotidi i oligonukleotidi, postupak za njihovo dobijanje i njihova upotreba
|
US6309639B1
(en)
|
1991-02-05 |
2001-10-30 |
The Board Of Regents Of The University Of Oklahoma |
Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
|
US6124267A
(en)
*
|
1991-02-05 |
2000-09-26 |
Southpac Trust Internationals, Inc. |
O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
|
US6136601A
(en)
*
|
1991-08-21 |
2000-10-24 |
Epoch Pharmaceuticals, Inc. |
Targeted mutagenesis in living cells using modified oligonucleotides
|
US6943034B1
(en)
*
|
1991-11-22 |
2005-09-13 |
Affymetrix, Inc. |
Combinatorial strategies for polymer synthesis
|
US6468740B1
(en)
|
1992-11-05 |
2002-10-22 |
Affymetrix, Inc. |
Cyclic and substituted immobilized molecular synthesis
|
DE69233331T3
(de)
*
|
1991-11-22 |
2007-08-30 |
Affymetrix, Inc., Santa Clara |
Kombinatorische Strategien zur Polymersynthese
|
US6849462B1
(en)
|
1991-11-22 |
2005-02-01 |
Affymetrix, Inc. |
Combinatorial strategies for polymer synthesis
|
US5652099A
(en)
*
|
1992-02-12 |
1997-07-29 |
Conrad; Michael J. |
Probes comprising fluorescent nucleosides and uses thereof
|
DE69333073T2
(de)
*
|
1992-02-12 |
2004-04-15 |
Chromagen, Inc., San Diego |
Verwendungen von fluoreszierenden n-nukleosiden und dessen analogen
|
TW323284B
(de)
*
|
1992-03-23 |
1997-12-21 |
Novartis Ag |
|
US6235886B1
(en)
*
|
1993-09-03 |
2001-05-22 |
Isis Pharmaceuticals, Inc. |
Methods of synthesis and use
|
US5695752A
(en)
*
|
1992-09-11 |
1997-12-09 |
The Regents Of The University Of California |
Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
|
AU4848793A
(en)
|
1992-09-11 |
1994-04-12 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide and nucleotide amine analogs, methods of synthesis and use
|
US6194144B1
(en)
|
1993-01-07 |
2001-02-27 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry
|
CA2114355A1
(en)
*
|
1993-01-29 |
1994-07-30 |
Hidehiko Furukawa |
Modified oligodeoxyribonucleotides, their preparation and their therapeutic use
|
US5412123A
(en)
*
|
1993-02-08 |
1995-05-02 |
Glycomed Incorporated |
Anthraquinone and anthracene derivatives as inhibitors of the cell-adhesion molecules of the immune system
|
US5955591A
(en)
*
|
1993-05-12 |
1999-09-21 |
Imbach; Jean-Louis |
Phosphotriester oligonucleotides, amidites and method of preparation
|
US5658880A
(en)
*
|
1993-06-16 |
1997-08-19 |
Glycomed Incorporated |
Sialic acid/fucose based medicaments
|
US5789385A
(en)
*
|
1993-06-16 |
1998-08-04 |
Glycomed Incorporated |
Sialyl Lewisx mimetics containing phenyl backbones
|
US5837689A
(en)
*
|
1993-06-16 |
1998-11-17 |
Glycomed Incorporated |
Sialyl lewis-x mimetics containing naphthyl backbones
|
US5508387A
(en)
*
|
1993-08-04 |
1996-04-16 |
Glycomed Incorporated |
Selectin binding glycopeptides
|
CA2174339A1
(en)
*
|
1993-10-27 |
1995-05-04 |
Lech W. Dudycz |
2'-amido and 2'-peptido modified oligonucleotides
|
US6071699A
(en)
|
1996-06-07 |
2000-06-06 |
California Institute Of Technology |
Nucleic acid mediated electron transfer
|
US5824473A
(en)
*
|
1993-12-10 |
1998-10-20 |
California Institute Of Technology |
Nucleic acid mediated electron transfer
|
US5591578A
(en)
*
|
1993-12-10 |
1997-01-07 |
California Institute Of Technology |
Nucleic acid mediated electron transfer
|
US5952172A
(en)
*
|
1993-12-10 |
1999-09-14 |
California Institute Of Technology |
Nucleic acid mediated electron transfer
|
US5575071A
(en)
*
|
1994-01-19 |
1996-11-19 |
Porter-Cable Corporation |
Toolless quickchange blade clamp for reciprocating saws
|
US7323298B1
(en)
|
1994-06-17 |
2008-01-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Microarray for determining the relative abundances of polynuceotide sequences
|
US5620850A
(en)
|
1994-09-26 |
1997-04-15 |
President And Fellows Of Harvard College |
Molecular recognition at surfaces derivatized with self-assembled monolayers
|
US8236493B2
(en)
*
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
FR2732344B1
(fr)
|
1995-04-03 |
1997-06-20 |
Genset Sa |
Oligonucleotides a liaison covalente transversale, procede de preparation et synthon utile dans le procede
|
EP0863910A1
(de)
|
1995-10-19 |
1998-09-16 |
NeXstar Pharmaceuticals, Inc. |
Verfahren zur herstellung von oligonucleotiden in lösungen
|
US5705621A
(en)
*
|
1995-11-17 |
1998-01-06 |
Isis Pharmaceuticals, Inc. |
Oligomeric phosphite, phosphodiester, Phosphorothioate and phosphorodithioate compounds and intermediates for preparing same
|
EP0880598A4
(de)
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
Verfahren zur analyse von nukleinsäure
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
US9096636B2
(en)
|
1996-06-06 |
2015-08-04 |
Isis Pharmaceuticals, Inc. |
Chimeric oligomeric compounds and their use in gene modulation
|
US7812149B2
(en)
|
1996-06-06 |
2010-10-12 |
Isis Pharmaceuticals, Inc. |
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
|
US6444423B1
(en)
|
1996-06-07 |
2002-09-03 |
Molecular Dynamics, Inc. |
Nucleosides comprising polydentate ligands
|
US6008334A
(en)
*
|
1996-07-24 |
1999-12-28 |
The Board Of Regents Of The University Of Oklahoma |
Base-protected nucleotide analogs with protected thiol groups
|
ATE292980T1
(de)
|
1996-10-11 |
2005-04-15 |
Univ California |
Immunostimulierende oligonucleotidekonjugate
|
US6096273A
(en)
*
|
1996-11-05 |
2000-08-01 |
Clinical Micro Sensors |
Electrodes linked via conductive oligomers to nucleic acids
|
US7014992B1
(en)
*
|
1996-11-05 |
2006-03-21 |
Clinical Micro Sensors, Inc. |
Conductive oligomers attached to electrodes and nucleoside analogs
|
US7393645B2
(en)
*
|
1996-11-05 |
2008-07-01 |
Clinical Micro Sensors, Inc. |
Compositions for the electronic detection of analytes utilizing monolayers
|
US7160678B1
(en)
|
1996-11-05 |
2007-01-09 |
Clinical Micro Sensors, Inc. |
Compositions for the electronic detection of analytes utilizing monolayers
|
US7381525B1
(en)
|
1997-03-07 |
2008-06-03 |
Clinical Micro Sensors, Inc. |
AC/DC voltage apparatus for detection of nucleic acids
|
US7045285B1
(en)
*
|
1996-11-05 |
2006-05-16 |
Clinical Micro Sensors, Inc. |
Electronic transfer moieties attached to peptide nucleic acids
|
EP0987273A4
(de)
|
1997-06-03 |
2001-11-07 |
Ajinomoto Kk |
Verfahren zur herstellung des fungzidies v-28-3m
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US20040006034A1
(en)
*
|
1998-06-05 |
2004-01-08 |
Eyal Raz |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
CA2291483C
(en)
|
1997-06-06 |
2012-09-18 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US6013459A
(en)
*
|
1997-06-12 |
2000-01-11 |
Clinical Micro Sensors, Inc. |
Detection of analytes using reorganization energy
|
DE19741084A1
(de)
*
|
1997-09-18 |
1999-03-25 |
Knoell Hans Forschung Ev |
Hochaffine Nukleinsäuremoleküle mit funktionellen Gruppen zur spezifischen Erkennung von Zielmolekülen, ihre Herstellung und Verwendung
|
US6686150B1
(en)
|
1998-01-27 |
2004-02-03 |
Clinical Micro Sensors, Inc. |
Amplification of nucleic acids with electronic detection
|
JP2002500897A
(ja)
|
1998-01-27 |
2002-01-15 |
クリニカル・マイクロ・センサーズ・インコーポレイテッド |
電子的核酸検出の増幅
|
US6562798B1
(en)
*
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
US6290839B1
(en)
|
1998-06-23 |
2001-09-18 |
Clinical Micro Sensors, Inc. |
Systems for electrophoretic transport and detection of analytes
|
US6761816B1
(en)
|
1998-06-23 |
2004-07-13 |
Clinical Micro Systems, Inc. |
Printed circuit boards with monolayers and capture ligands
|
US7087148B1
(en)
|
1998-06-23 |
2006-08-08 |
Clinical Micro Sensors, Inc. |
Binding acceleration techniques for the detection of analytes
|
US6716394B2
(en)
|
1998-08-11 |
2004-04-06 |
Caliper Technologies Corp. |
DNA sequencing using multiple fluorescent labels being distinguishable by their decay times
|
US6447724B1
(en)
|
1998-08-11 |
2002-09-10 |
Caliper Technologies Corp. |
DNA sequencing using multiple fluorescent labels being distinguishable by their decay times
|
EP1104491A4
(de)
*
|
1998-08-11 |
2003-01-29 |
Caliper Techn Corp |
Verfahren und systeme zur sequenzierung von dna mkittels unterscheidung der zerfallszeiten fluoreszierender sonden
|
US6288221B1
(en)
|
1998-08-20 |
2001-09-11 |
Duke University |
Methods of synthesis of halogen base-modified oligonucleotides and subsequent labeling with a metal-catalyzed reaction
|
US6740518B1
(en)
|
1998-09-17 |
2004-05-25 |
Clinical Micro Sensors, Inc. |
Signal detection techniques for the detection of analytes
|
DE69931377T2
(de)
*
|
1998-09-18 |
2007-05-10 |
Dynavax Technologies Corp., Berkeley |
Verfahren zur behandlung von ig-e assozierten krankheiten und zusammensetzungen zur verwendung in diesen verfahren
|
WO2000024941A1
(en)
|
1998-10-27 |
2000-05-04 |
Clinical Micro Sensors, Inc. |
Detection of target analytes using particles and electrodes
|
US6545264B1
(en)
|
1998-10-30 |
2003-04-08 |
Affymetrix, Inc. |
Systems and methods for high performance scanning
|
US6184347B1
(en)
|
1998-11-19 |
2001-02-06 |
Agilent Technologies Inc. |
Minimization of blooming in high-density arrays by using reactive wash reagents
|
US6264891B1
(en)
*
|
1998-12-22 |
2001-07-24 |
Eos Biotechnology, Inc. |
Apparatus and method for concurrent chemical synthesis
|
US6833267B1
(en)
|
1998-12-30 |
2004-12-21 |
Clinical Micro Sensors, Inc. |
Tissue collection devices containing biosensors
|
WO2000056749A1
(en)
|
1999-03-24 |
2000-09-28 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
N-acylphosphoramidites and their use in oligonucleotide synthesis
|
US20020177135A1
(en)
*
|
1999-07-27 |
2002-11-28 |
Doung Hau H. |
Devices and methods for biochip multiplexing
|
US7312087B2
(en)
|
2000-01-11 |
2007-12-25 |
Clinical Micro Sensors, Inc. |
Devices and methods for biochip multiplexing
|
US6942771B1
(en)
|
1999-04-21 |
2005-09-13 |
Clinical Micro Sensors, Inc. |
Microfluidic systems in the electrochemical detection of target analytes
|
WO2001007665A2
(en)
|
1999-07-26 |
2001-02-01 |
Clinical Micro Sensors, Inc. |
Sequence determination of nucleic acids using electronic detection
|
ATE419869T1
(de)
|
1999-08-19 |
2009-01-15 |
Dynavax Tech Corp |
Methode zur modulierung eines immunantwortes mit immunstimulierenden sequencen und zusammensetzungen dafür
|
DE60002821T2
(de)
*
|
1999-08-27 |
2004-05-06 |
Japan Science And Technology Corp., Kawaguchi |
Reversibel photokuppelnde nukleinsäure und phosphoramidit
|
US6395142B1
(en)
*
|
1999-10-14 |
2002-05-28 |
Chemcycles, Inc. |
Method and apparatus for purifying low grade acetonitrile and other constituents from hazardous waste
|
US7223398B1
(en)
|
1999-11-15 |
2007-05-29 |
Dynavax Technologies Corporation |
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
|
US20020098199A1
(en)
|
2000-03-10 |
2002-07-25 |
Gary Van Nest |
Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
|
US7157437B2
(en)
*
|
2000-03-10 |
2007-01-02 |
Dynavax Technologies Corporation |
Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
|
US20020028784A1
(en)
*
|
2000-03-10 |
2002-03-07 |
Nest Gary Van |
Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
|
US20010046967A1
(en)
*
|
2000-03-10 |
2001-11-29 |
Gary Van Nest |
Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
|
US20020107212A1
(en)
*
|
2000-03-10 |
2002-08-08 |
Nest Gary Van |
Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
US6753143B2
(en)
|
2000-05-01 |
2004-06-22 |
Clinical Micro Sensors, Inc. |
Target analyte detection using asymmetrical self-assembled monolayers
|
JP4382265B2
(ja)
*
|
2000-07-12 |
2009-12-09 |
日本電気株式会社 |
酸化シリコン膜の形成方法及びその形成装置
|
US6397150B1
(en)
|
2000-07-27 |
2002-05-28 |
Visible Genetics Inc. |
Method and apparatus for sequencing of DNA using an internal calibrant
|
EP1364010B1
(de)
*
|
2000-12-27 |
2010-06-16 |
Dynavax Technologies Corporation |
Immunomodulatorische polynukleotide und verfahren zur deren verwendung
|
US6541626B2
(en)
*
|
2001-04-17 |
2003-04-01 |
Isis Pharmaceuticals, Inc. |
Process for selective N-acylation of purine nucleosides
|
EP2423335B1
(de)
*
|
2001-06-21 |
2014-05-14 |
Dynavax Technologies Corporation |
Chimäre immunmodulierende Verbindungen und Verwendungsverfahren dafür
|
US7785610B2
(en)
*
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
US20030133988A1
(en)
*
|
2001-08-07 |
2003-07-17 |
Fearon Karen L. |
Immunomodulatory compositions, formulations, and methods for use thereof
|
US7222059B2
(en)
*
|
2001-11-15 |
2007-05-22 |
Siemens Medical Solutions Diagnostics |
Electrophoretic trace simulator
|
US7355037B2
(en)
*
|
2001-12-03 |
2008-04-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Thermolabile hydroxyl protecting groups and methods of use
|
ATE508188T1
(de)
|
2002-02-01 |
2011-05-15 |
Life Technologies Corp |
Oligonukleotid-zusammensetzungen mit verbesserter wirksamkeit
|
EP1572902B1
(de)
|
2002-02-01 |
2014-06-11 |
Life Technologies Corporation |
HOCHWIRKSAME siRNAS ZUR REDUZIERUNG DER EXPRESSION VON ZIELGENEN
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
FR2840611B1
(fr)
*
|
2002-06-06 |
2005-09-09 |
Cis Bio Int |
Entite fluorescente comportant un fluorophore lie de maniere covalente a au moins un oligonucleotide et comportant au moins un groupe fonctionnel et ses utilisations
|
US20040248094A1
(en)
*
|
2002-06-12 |
2004-12-09 |
Ford Lance P. |
Methods and compositions relating to labeled RNA molecules that reduce gene expression
|
US20100075423A1
(en)
*
|
2002-06-12 |
2010-03-25 |
Life Technologies Corporation |
Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
|
AU2003243541A1
(en)
*
|
2002-06-12 |
2003-12-31 |
Ambion, Inc. |
Methods and compositions relating to labeled rna molecules that reduce gene expression
|
NZ538628A
(en)
|
2002-08-12 |
2008-06-30 |
Dynavax Tech Corp |
Immunomodulatory compositions, methods of making, and methods of use thereof
|
WO2004027030A2
(en)
*
|
2002-09-18 |
2004-04-01 |
Isis Pharmaceuticals, Inc. |
Efficient reduction of target rna’s by single- and double-stranded oligomeric compounds
|
US7534872B2
(en)
*
|
2002-09-27 |
2009-05-19 |
Syngen, Inc. |
Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis
|
WO2004044139A2
(en)
|
2002-11-05 |
2004-05-27 |
Isis Parmaceuticals, Inc. |
Modified oligonucleotides for use in rna interference
|
EP1575977B1
(de)
|
2002-12-23 |
2009-09-09 |
Dynavax Technologies Corporation |
Oligonukleotide mit einer immunsystemstimulierenden sequenz und verfahren zu deren anwendung
|
US7625872B2
(en)
*
|
2002-12-23 |
2009-12-01 |
Dynavax Technologies Corporation |
Branched immunomodulatory compounds and methods of using the same
|
US8158768B2
(en)
*
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
US8569474B2
(en)
|
2004-03-09 |
2013-10-29 |
Isis Pharmaceuticals, Inc. |
Double stranded constructs comprising one or more short strands hybridized to a longer strand
|
WO2005107404A2
(en)
*
|
2004-05-03 |
2005-11-17 |
The Penn State Research Foundation |
Methods and systems for nanoparticle enhancement of signals
|
AU2005252662B2
(en)
*
|
2004-06-03 |
2011-08-18 |
Isis Pharmaceuticals, Inc. |
Double strand compositions comprising differentially modified strands for use in gene modulation
|
US8394947B2
(en)
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
US20080286880A1
(en)
*
|
2004-07-07 |
2008-11-20 |
The Penn State Research Foundation |
Methods and Systems for Nanoparticle Enhancement of Signals
|
EP1788875A4
(de)
|
2004-08-20 |
2010-12-15 |
Dharmacon Inc |
Neue polynukleotidsynthese durch markierungschemie
|
PL1794174T3
(pl)
*
|
2004-09-01 |
2012-11-30 |
Dynavax Tech Corp |
Sposoby i kompozycje do hamowania wrodzonych odpowiedzi immunologicznych i autoodporności
|
US7884086B2
(en)
|
2004-09-08 |
2011-02-08 |
Isis Pharmaceuticals, Inc. |
Conjugates for use in hepatocyte free uptake assays
|
DK2302055T3
(da)
|
2004-11-12 |
2014-10-13 |
Asuragen Inc |
Fremgangsmåder og sammensætninger involverende miRNA og miRNA-inhibitormolekyler
|
WO2006065751A2
(en)
*
|
2004-12-13 |
2006-06-22 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
|
WO2006066003A2
(en)
*
|
2004-12-17 |
2006-06-22 |
Dynavax Technologies Corporation |
Methods and compositions for induction or promotion of immune tolerance
|
US20060142228A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Ambion, Inc. |
Methods and compositions concerning siRNA's as mediators of RNA interference
|
WO2006081623A1
(en)
*
|
2005-02-04 |
2006-08-10 |
The Australian National University |
Double-stranded oligonucleotides and uses therefor
|
EP2094849B1
(de)
*
|
2006-11-09 |
2014-01-08 |
Dynavax Technologies Corporation |
Langfristige modifikation einer erkrankung mithilfe immunstimulatorischer oligonukleotide
|
US7951789B2
(en)
|
2006-12-28 |
2011-05-31 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
EP2209896B1
(de)
*
|
2007-10-26 |
2017-03-01 |
Dynavax Technologies Corporation |
Verfahren und zusammensetzungen zur hemmung von immunantworten und autoimmunität
|
JP5115312B2
(ja)
*
|
2008-05-02 |
2013-01-09 |
ソニー株式会社 |
核酸分離用担体の製造方法、及び核酸分離用担体とマイクロ流路系、並びに核酸分離方法と核酸分離装置
|
CA2724418A1
(en)
*
|
2008-05-15 |
2009-11-19 |
Dynavax Technologies Corporation |
Long term disease modification using immunostimulatory oligonucleotides
|
MX2012011222A
(es)
|
2010-04-01 |
2013-01-18 |
Centre Nat Rech Scient |
Compuestos y composiciones farmaceuticas para el tratamiento de infecciones virales.
|
KR101810593B1
(ko)
|
2010-06-16 |
2017-12-22 |
다이나박스 테크놀로지 코퍼레이션 |
Tlr7 및/또는 tlr9 억제제를 사용하는 치료 방법
|
WO2012110824A1
(en)
|
2011-02-18 |
2012-08-23 |
Astrazeneca Ab |
Binding agents with specificity for a nucleic acid modification
|
WO2012154321A1
(en)
|
2011-03-31 |
2012-11-15 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
US9228184B2
(en)
|
2012-09-29 |
2016-01-05 |
Dynavax Technologies Corporation |
Human toll-like receptor inhibitors and methods of use thereof
|
JP6358955B2
(ja)
|
2012-10-31 |
2018-07-18 |
武田薬品工業株式会社 |
新規修飾核酸
|
AU2014306271A1
(en)
|
2013-08-08 |
2016-03-24 |
The Scripps Research Institute |
A method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides
|
DK3129493T3
(da)
|
2014-04-09 |
2021-09-27 |
Scripps Research Inst |
Import af unaturlige eller modificerede nukleosidtriphosphater ind i celler via nukleinsyre-triphosphat-transportører
|
US11761007B2
(en)
|
2015-12-18 |
2023-09-19 |
The Scripps Research Institute |
Production of unnatural nucleotides using a CRISPR/Cas9 system
|
ES2929047T3
(es)
|
2016-06-24 |
2022-11-24 |
Scripps Research Inst |
Transportador de nucleósido trifosfato novedoso y usos del mismo
|
JP7325341B2
(ja)
|
2017-07-11 |
2023-08-14 |
シンソークス,インク. |
非天然ヌクレオチドの組み込み及びその方法
|
NZ761430A
(en)
|
2017-08-03 |
2024-03-22 |
Synthorx Inc |
Cytokine conjugates for the treatment of proliferative and infectious diseases
|
JP2021514974A
(ja)
|
2018-02-26 |
2021-06-17 |
シンソークス, インコーポレイテッド |
Il−15コンジュゲートおよびその使用
|
BR112021014415A2
(pt)
|
2019-02-06 |
2021-09-21 |
Synthorx, Inc. |
Conjugados de il-2 e métodos de uso dos mesmos
|
TW202113078A
(zh)
|
2019-06-14 |
2021-04-01 |
美商史基普研究協會 |
於半合成生物體中複製、轉錄及轉譯之試劑及方法
|
MX2022001776A
(es)
|
2019-08-15 |
2022-03-17 |
Synthorx Inc |
Terapias de combinacion de inmuno oncologia con conjugados de il-2.
|
MX2022002053A
(es)
|
2019-08-23 |
2022-03-17 |
Synthorx Inc |
Conjugados de il-15 y sus usos.
|
US20210070827A1
(en)
|
2019-09-10 |
2021-03-11 |
Synthorx, Inc. |
Il-2 conjugates and methods of use to treat autoimmune diseases
|
TW202131952A
(zh)
|
2019-11-04 |
2021-09-01 |
美商欣爍克斯公司 |
介白素10接合物及其用途
|
KR20230027235A
(ko)
|
2020-06-25 |
2023-02-27 |
신톡스, 인크. |
Il-2 콘쥬게이트 및 항-egfr 항체를 사용한 면역 종양학 병용 요법
|
AU2021356610A1
(en)
|
2020-10-09 |
2023-06-15 |
Synthorx, Inc. |
Immuno oncology therapies with il-2 conjugates
|
MX2023004029A
(es)
|
2020-10-09 |
2023-04-27 |
Synthorx Inc |
Terapia de combinacion de inmunoncologia con conjugados de il-2 y pembrolizumab.
|
WO2022174101A1
(en)
|
2021-02-12 |
2022-08-18 |
Synthorx, Inc. |
Skin cancer combination therapy with il-2 conjugates and cemiplimab
|
WO2022174102A1
(en)
|
2021-02-12 |
2022-08-18 |
Synthorx, Inc. |
Lung cancer combination therapy with il-2 conjugates and an anti-pd-1 antibody or antigen-binding fragment thereof
|
WO2022256538A1
(en)
|
2021-06-03 |
2022-12-08 |
Synthorx, Inc. |
Head and neck cancer combination therapy comprising an il-2 conjugate and cetuximab
|
WO2023122573A1
(en)
|
2021-12-20 |
2023-06-29 |
Synthorx, Inc. |
Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
|
WO2023122750A1
(en)
|
2021-12-23 |
2023-06-29 |
Synthorx, Inc. |
Cancer combination therapy with il-2 conjugates and cetuximab
|